462 related articles for article (PubMed ID: 35806355)
1. The Diabetic Cardiorenal Nexus.
D'Elia JA; Bayliss GP; Weinrauch LA
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806355
[TBL] [Abstract][Full Text] [Related]
2. Negotiating renal dysfunction when treating patients with heart failure.
Carubelli V; Metra M; Lund LH
Expert Rev Cardiovasc Ther; 2018 Feb; 16(2):113-122. PubMed ID: 29292652
[TBL] [Abstract][Full Text] [Related]
3. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.
McCullough PA; Amin A; Pantalone KM; Ronco C
J Am Heart Assoc; 2022 Jun; 11(11):e024139. PubMed ID: 35616212
[TBL] [Abstract][Full Text] [Related]
4. Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.
Agrawal A; Naranjo M; Kanjanahattakij N; Rangaswami J; Gupta S
Heart Fail Rev; 2019 Jul; 24(4):421-437. PubMed ID: 31127482
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Rangaswami J; Bhalla V; Blair JEA; Chang TI; Costa S; Lentine KL; Lerma EV; Mezue K; Molitch M; Mullens W; Ronco C; Tang WHW; McCullough PA;
Circulation; 2019 Apr; 139(16):e840-e878. PubMed ID: 30852913
[TBL] [Abstract][Full Text] [Related]
6. Acute cardiorenal syndrome: Mechanisms and clinical implications.
Thind GS; Loehrke M; Wilt JL
Cleve Clin J Med; 2018 Mar; 85(3):231-239. PubMed ID: 29522391
[TBL] [Abstract][Full Text] [Related]
7. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.
Rieger AC; Tompkins BA; Natsumeda M; Florea V; Banerjee MN; Rodriguez J; Rosado M; Porras V; Valasaki K; Takeuchi LM; Collon K; Desai S; Bellio MA; Khan A; Kashikar ND; Landin AM; Hardin DV; Rodriguez DA; Balkan W; Hare JM; Schulman IH
Stem Cells Transl Med; 2022 Mar; 11(1):59-72. PubMed ID: 35641169
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal syndrome: Decongestion in heart failure across wide spectrum of kidney pathophysiology.
Kosiorek A; Biegus J; Rozentryt P; Hurkacz M; Zymliński R
Adv Clin Exp Med; 2022 Apr; 31(4):445-455. PubMed ID: 34995423
[TBL] [Abstract][Full Text] [Related]
11. New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy.
Gallo G; Lanza O; Savoia C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982164
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal syndrome: review of our current understanding.
Hadjiphilippou S; Kon SP
J R Soc Med; 2016 Jan; 109(1):12-7. PubMed ID: 26609123
[TBL] [Abstract][Full Text] [Related]
13. Renal implications of pulmonary arterial capacitance in acute heart failure with preserved ejection fraction.
Toroghi HM; Lo KB; Ziccardi MR; Horn B; Kanjanahattakij N; Malik E; Penalver J; Rangaswami J; Gupta S; Amanullah A
Rev Cardiovasc Med; 2019 Dec; 20(4):267-272. PubMed ID: 31912718
[TBL] [Abstract][Full Text] [Related]
14. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
15. Associations of anemia and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction.
Kajimoto K; Sato N; Keida T; Sakata Y; Takano T;
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1912-21. PubMed ID: 25183660
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets.
Takahama H; Kitakaze M
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H715-H721. PubMed ID: 28733448
[TBL] [Abstract][Full Text] [Related]
17. Cardionephrology and cardiorenal disease in Italy: state of the art.
Di Lullo L; Bellasi A; Barbera V; Ronco C
Rev Cardiovasc Med; 2021 Sep; 22(3):563-572. PubMed ID: 34565060
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal dialysis in patients with heart failure.
Van Der Sande FM; Cnossen TT; Cornelis T; Konings CJ; Kooman JP; Leunissen KM
Minerva Urol Nefrol; 2012 Sep; 64(3):163-72. PubMed ID: 22971681
[TBL] [Abstract][Full Text] [Related]
19. Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under-diagnosed disease.
Prastaro M; Nardi E; Paolillo S; Santoro C; Parlati ALM; Gargiulo P; Basile C; Buonocore D; Esposito G; Filardi PP
J Clin Ultrasound; 2022 Oct; 50(8):1110-1124. PubMed ID: 36218199
[TBL] [Abstract][Full Text] [Related]
20. Cardiorenal Syndrome: An Important Subject in Nephrocardiology.
Hatamizadeh P
Cardiol Clin; 2021 Aug; 39(3):455-469. PubMed ID: 34247758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
